Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy -- AKT/m-TOR Pathway and Resistance to Cancer Therapy.

MLA

Spirina, Liudmila V., et al. “Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy -- AKT/m-TOR Pathway and Resistance to Cancer Therapy.” Chinese Journal of Lung Cancer, vol. 21, no. 1, Jan. 2018, pp. 63–66. EBSCOhost, https://doi.org/10.3779/j.issn.1009-3419.2018.01.09.

APA

Spirina, L. V., Kondakova, I. V., Tarasenko, N. V., Slonimskaya, E. M., Usynin, E. A., Gorbunov, A. K., Yurmazov, Z. A., & Chigevskaya, S. Y. (2018). Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy -- AKT/m-TOR Pathway and Resistance to Cancer Therapy. Chinese Journal of Lung Cancer, 21(1), 63–66. https://doi.org/10.3779/j.issn.1009-3419.2018.01.09

Chicago

Spirina, Liudmila V., Irina V. Kondakova, Natalia V. Tarasenko, Elena M. Slonimskaya, Evgeny A. Usynin, Alexey K. Gorbunov, Zahar A. Yurmazov, and Svetlana Yu Chigevskaya. 2018. “Targeting of the AKT/m-TOR Pathway: Biomarkers of Resistance to Cancer Therapy -- AKT/m-TOR Pathway and Resistance to Cancer Therapy.” Chinese Journal of Lung Cancer 21 (1): 63–66. doi:10.3779/j.issn.1009-3419.2018.01.09.